Clinical Trial 55505

Phoenix, AZ 85018


A Randomized, Multi-regional, Double-blind, Double-dummy Parallel-group Phase 3 study to assess the efficacy and safety of study medication in Gout patients with Hyperuricemia. 

  • Male or Female 18-85 years old
  • Have gout with hyperuricemia
  • BMI <50 kg
  • Not experiencing an active acute gout attack within 2 weeks prior to screening
  • No uncontrolled severe pain (e.g. servere osteoarthritis, back pain) 
  • No cancer in the last 5 years

Qualified Participants May Receive:

Compensation for time and travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.